Traduction de «of certain other substances » (Néerlandais → Français) :

narcotics and concerning risk limitation and therapeutic advice and of 22 January 1998 governing certain psychotropic substances and concerning risk limitation and therapeutic advice and of 12 April 1974 containing certain provisions relating to substances with hormonal, antihormonal, anabolic, beta-adrenergic, anti-infectious, antiparasitic and anti-inflammatory action Law of 15 July 1985 on the use in animals of substances with hormonal, anti-hormonal, beta-adrenergic or production stimulating action Law of 13 June 1986 on the removal and transplanting of organs, with regard to cells and tissues Law of 28 August 1991 on the practice of veterinary medicine, regarding the provision of medicines to animal carers Law of 5 July 1994 on blood and blood derivatives of human origin Law of 7 May 2004 on experiments on the human person Royal decree of 31 May 1885 approving new instructions for physicians, pharmacists and druggists Royal decree of 22 September 1966 on the conditions and arrangements for the recognition of laboratories for the analysis and checking of medicines Royal decree of 6 June 1960 on the production, preparation and wholesale distribution and delivery of medicines Royal decree no. 78 of 10 November 1967 on the practice of the healthcare professions regarding the dispensing of medicines to the public and Royal decree of 25 September
narcotics and concerning risk limitation and therapeutic advice and of 22 January 1998 governing certain psychotropic substances and concerning risk limitation and therapeutic advice and of 12 April 1974 containing certain provisions relating to substances with hormonal, antihormonal, anabolic, beta-adrenergic, anti-infectious, antiparasitic and anti-inflammatory action Law of 15 July 1985 on the use in animals of substances with hormonal, anti-hormonal, beta-adrenergic or production stimulating action Law of 13 June 1986 on the removal and transplanting of organs, with regard to cells and tissues Law of 28 August 1991 on the practice of veterinary medicine, regarding the provision of medicines to animal carers Law of 5 July 1994 on blood and blood derivatives of human origin Law of 7 May 2004 on experiments on the human person Royal decree of 31 May 1885 approving new instructions for physicians, pharmacists and druggists Royal decree of 22 September 1966 on the conditions and arrangements for the recognition of laboratories for the analysis and checking of medicines Royal decree of 6 June 1960 on the production, preparation and wholesale distribution and delivery of medicines Royal decree no. 78 of 10 November 1967 on the practice of the healthcare professions regarding the dispensing of medicines to the public and Royal decree of 25 September

Parliament and of the Council of 20 December 2006 on the addition of vitamins and minerals and of certain other substances to foods.
- CE – Commission européenne. Regulation (EC) No 1925/2006 of the European Parliament and of the Council of 20 December 2006 on the addition of vitamins and minerals and of certain other substances to foods.

Likewise, research carried out up to now has shown that there appears to be a definite connection in all countries, both industrial and developing countries, between alcohol consumption (notably in the Russian Federation and the Baltic states), free access to certain toxic substances (e.g. in China, India and Sri Lanka) and firearms (e.g. in El Salvador and the United States) on the one hand, and the rate of suicide on the other.
De même, la consommation d’alcool (notamment en Fédération de Russie et dans les Etats baltes) ainsi que le libre accès à certaines substances toxiques (en Chine, en Inde et au Sri Lanka, par exemple) et aux armes à feu (à El Salvador et aux Etats-Unis d’Amérique, entre autres) semblent, d’après les études réalisées jusqu’à présent, associés de façon certaine aux taux de suicide dans tous les pays, industrialisés ou en développement.

Set up in partnership with other ministers evidence-based education programmes addressing suicide, depression, alcohol and other substance use disorders for young people at schools and universities and involve role models and young people in the making of campaigns. viii.
For families at risk, provide home-based educational interventions to help proactively to improve parenting skills, health behaviour and interaction between parents and children. vii. Set up in partnership with other ministers evidence-based education programmes addressing suicide, depression, alcohol and other substance use disorders for young people at schools and universities and involve role models and young people in the making of campaigns. viii.

Ingesting toxic substances, alcohol or other, whilst suffering from a DSM-IV axis I or II pathology, can constitute an important risk factor, regardless of whether this happens occasionally or as a result of regular abuse or dependence.
La prise de toxiques, alcool ou autre, qu’elle soit occasionnelle ou organisée en abus ou dépendance, en résonance avec une pathologie de l’axe I ou de l’axe II du DSM-IV, peut constituer un facteur de risque important.

concerned about the increased risk of potentially harmful caffeine-abuse and all its consequences (such as insomnia, nervousness, anxiety, headache, trembling and tachycardia), as well as the fact that these beverages may induce an addiction to caffeine or, as has been discovered more recently, a dependence on other substances (nicotine, alcohol and/or cannabis).
En conséquence, le Conseil Supérieur de la Santé prend acte de la mise à disposition de données rassurantes sur l’innocuité de deux principaux composants des boissons énergisantes, à savoir la taurine et la D-glucuronolactone, mais reste préoccupé par le risque accru qu’elles entraînent d’une surconsommation potentiellement nuisible de caféine, avec les conséquences que celle-ci implique telles que insomnie, nervosité, anxiété, maux de tête, tremblements et tachycardie, mais également, la possibilité d’induction d’une dépendance à la caféine ou à d’autres substances (nicotine, alcool et/ou cannabis), plus récemment évoquée.

However, the Council remains concerned that these energy drinks increase the risk of excessive and potentially harmful caffeine consumption and its consequences (such as insomnia, nervousness, anxiety, headaches, trembling and tachycardia), as well as the risk of potentially inducing an addiction to caffeine and, as has been noted more recently, a dependence on other substances (nicotine, alcohol and/or cannabis).
Il reste néanmoins préoccupé par le risque accru d’une surconsommation potentiellement nuisible de caféine et des conséquences que celle-ci implique telles que insomnie, nervosité, anxiété, maux de tête, tremblements et tachycardie, mais également, la possibilité d’induction d’une dépendance à la caféine ou à d’autres substances (nicotine, alcool et/ou cannabis), plus récemment évoquée.

Risk factors that cannot be changed (such as a previous attempted suicide) can alert others to the heightened risk of suicide during periods of the recurrence of a mental or substance abuse disorder following a particularly stressful life event (Oquendo et al., 1999).
Les facteurs de risque qui ne peuvent pas être changés (comme les tentatives de suicide antérieures) peuvent alerter les autres du risque accru de suicide durant des périodes de récurrence de troubles mentaux ou d’abus de substances à la suite d’un événement de vie particulièrement stressant (Oquendo et al., 1999).

Average Wholesale Price litigation Claims have been brought against various pharmaceutical companies, including NPC and certain Sandoz entities, alleging that they fraudulently overstated the Average Wholesale Price and “best price”, which are, or have been, used by the US federal and state governments in the calculation of, respectively, Medicare reimbursements and Medicaid rebates. In some cases, motions to dismiss or (cross-) motions for summary judgment in other cases have been made and are currently pending.
Litige concernant le prix de gros moyen Des plaintes ont été déposées contre différentes sociétés pharmaceutiques, dont NPC et certaines entités de Sandoz, au motif que celles-ci auraient frauduleusement exagéré le prix de gros moyen (average wholesale price [AWP]) et le «meilleur prix» qui sont ou ont été utilisés par le gouvernement fédéral américain et des gouvernements d’Etat pour calculer les remboursements des médicaments dans le cadre du programme Medicare et les rabais dans celui de Medicaid.

The reason behind this ambition is certainly not obvious: the competent medicines authorities in other Member States have the same ambition and vaccinology is, in epidemiological terms, a very broad domain, ranging from the prevention of neonatal pathology to hospital infections to sexually transmitted diseases.
The reason behind this ambition is certainly not obvious: the competent medicines authorities in other Member States have the same ambition and vaccinology is, in epidemiological terms, a very broad domain, ranging from the prevention of neonatal pathology to hospital infections to sexually transmitted diseases.